|
시장보고서
상품코드
1701506
세계의 바이오소재 시장 규모, 점유율, 성장 분석 : 유형별, 용도별, 지역별 - 산업 예측(2025-2032년)Biomaterials Market Size, Share, and Growth Analysis, By Type (Metallic Biomaterials, Polymeric Biomaterials), By Application (Orthopedic, Cardiovascular), By Region - Industry Forecast 2025-2032 |
||||||
바이오 소재 시장 규모는 2023년 1,756억 달러로 평가되었고, 2024년 1,991억 3,000만 달러에서 2032년 5,445억 6,000만 달러에 달하고, 예측 기간(2025-2032년) 동안 13.4%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.
세계 바이오소재 시장은 고령화, 심장병 및 관절 질환 증가, 헬스케어 기술의 발전, 임플란트 기기에 대한 일반인의 인식 증가 등을 배경으로 큰 성장을 거듭하고 있습니다. 바이오소재 연구개발에 대한 정부의 지원과 소비자의 바이오소재에 대한 이해도가 높아진 것도 시장 확대에 기여하고 있습니다. 그러나 생체재료 임플란트의 적합성 문제, 높은 비용 등의 문제가 성장의 걸림돌이 될 수 있습니다. 하지만 이식용 탈세포화 진피 매트릭스, 수소 스캐폴더와 같은 새로운 기술이 신경학, 상처 치유, 성형외과 분야의 혁신적 제품과 함께 유리한 기회를 창출할 것으로 예측됩니다. 이식형 생체재료의 주요 목적은 생물학적 기능을 향상시키면서 유해한 면역반응을 최소화하는 것이며, 궁극적으로 여러 분야에 걸친 다양한 질환을 치료하는 데 있습니다.
Biomaterials Market size was valued at USD 175.6 billion in 2023 and is poised to grow from USD 199.13 billion in 2024 to USD 544.56 billion by 2032, growing at a CAGR of 13.4% during the forecast period (2025-2032).
The global biomaterials market is experiencing significant growth driven by an aging population, increasing heart disease and joint issues, advancements in healthcare technology, and heightened public awareness of implanted devices. Government support for biomaterials R&D and greater consumer understanding of these products further contribute to market expansion. However, challenges such as compatibility issues and high costs of biomaterial implants may hinder growth. Nevertheless, emerging technologies, including decellularized dermal matrixes for grafting and hydrogen scaffolding, along with innovative products in neurology, wound healing, and plastic surgery, are expected to create lucrative opportunities. The primary aim of implantable biomaterials is to minimize adverse immune responses while enhancing biological function, ultimately addressing various medical conditions across multiple disciplines.
Top-down and bottom-up approaches were used to estimate and validate the size of the Biomaterials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Biomaterials Market Segments Analysis
Global Biomaterials Market is segmented by Type, Application and region. Based on Type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials and Other Natural Biomaterials. Based on Application, the market is segmented into Orthopedic, Cardiovascular, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Neurological/Central Nervous System, Urinary and Other Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Biomaterials Market
The growing demand for biomaterials in wound healing and plastic surgery significantly drives the biomaterials market. These innovative materials are widely utilized for various applications, including the implantation, reconstruction, and healing of burns, as well as addressing holes in the body and soft tissue injuries. Their ability to facilitate natural and safe recovery makes them essential in medical procedures. As healthcare professionals increasingly recognize the advantages of biomaterial-based products, the expansion of their use in cosmetic and reconstructive surgeries fuels market growth. This trend underscores the pivotal role biomaterials play in advancing medical treatments and improving patient outcomes.
Restraints in the Biomaterials Market
Orthopedic injuries and associated disorders result in significant impairment and suffering, representing a critical concern for global public health. These conditions often necessitate surgical interventions that involve the use of medical devices, which can be categorized as long-term, short-term, or biodegradable. Such procedures require the integration of various natural or synthetic biomaterials to effectively repair or replace essential tissues, including ligaments, tendons, cartilage, and bone. The continued reliance on these devices highlights the crucial role of biomaterials in addressing complex orthopedic challenges, yet underscores the pressing need to enhance their effectiveness and reduce complications in clinical settings.
Market Trends of the Biomaterials Market
The global biomaterials market is experiencing a significant upward trend driven by the rising demand for biodegradable materials, particularly in medical applications such as tissue engineering, wound healing, and drug delivery systems. These innovative materials are gaining preference due to their ability to safely degrade within the human body, minimizing the need for additional surgical interventions and enhancing patient recovery. As healthcare providers and patients increasingly prioritize sustainable and biocompatible options, the push towards biodegradable biomaterials is expected to accelerate. This shift not only reflects a commitment to improved health outcomes but also aligns with growing environmental concerns, further solidifying biodegradable biomaterials' relevance in the market.